Webinar: A First Look at BioCentriq™
Watch the Webinar
RIBBON CUTTING & VIRTUAL TOUR OF BIOCENTRIQ™
Dr. Bloom Opening Remarks
Governor Murphy Remarks
NJII BioCentriq Tour
New Jersey: A Rising Cell & Gene Therapy Hub
This historic webinar showcased the next era of cell and gene therapy in New Jersey. BioCentriq™ is a new state-of-the-art cell and gene therapy development center located at the New Jersey Institute of Technology (NJIT). This event was brought to you in partnership by New Jersey Innovation Institute (NJII) and Choose New Jersey.
Watch the video to tour this brand new industry-facing contract development and manufacturing organization (CDMO) dedicated to cell and gene therapies. Located in Newark, NJ on the campus of NJIT, BioCentriq™ features GMP suites for clinical production of cell & gene therapies and a process development pilot plant. The center is poised to attract global leaders in the biopharmaceutical industry as well as promising start-ups, which will develop new and innovative therapies.
DATE: Thursday, October 29, 2020
TIME: 2:30pm – 3:30pm EST
Opening Remarks
Joel Bloom, Ed.D.
President
New Jersey Institute of Technology (NJIT)
Governor
Phil Murphy
State of New Jersey
Robert Cohen
President, Digital, Robotics, and Enabling Technology
Stryker
Simon Nynens
CEO
New Jersey Innovation Institute (NJII)
Dr. Peter Marks MD, PhD
Director of the Center for Biologics Evaluation and Research (CBER)
U.S. Food and Drug Administration (FDA)
RIBBON CUTTING & VIRTUAL TOUR OF BIOCENTRIQ™
Led by Dr. Haro Hartounian, SVP & General Manager of the Biopharma Division at NJII, we cut the ribbon and opened the doors of BioCentriq™. Attendees were among the first to see the two state-of-the art GMP suites now open and available for your next project.
PANEL: THE KEYS TO THE FUTURE OF
CELL & GENE THERAPY MANUFACTURING
A robust panel discussion and live Q&A with leaders in the industry.
HARO HARTOUNIAN, Ph.D.
SVP & General Manager of the Biopharma Division, New Jersey Innovation Institute (NJII)
(Moderator)
KELVIN H. LEE, Ph.D.
Director, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
Janet Lynch Lambert
Chief Executive Officer
Alliance for Regenerative Medicine
Greg Russotti, Ph.D.
Chief Technology Officer Century Therapeutics, LLC
PANEL: Why Choose New Jersey for Cell & Gene Therapy
From lab to shelf, New Jersey’s diverse and expansive life sciences ecosystem has the support, funding and resources needed for success. Watch the recap to learn about the resources available to those who choose to bring their cell and gene therapy projects and businesses to New Jersey.
Debbie Hart
President & CEO
BioNJ
Jose Lozano
President & CEO
Choose New Jersey
Kathleen Coviello
Executive Vice President for Technology, Life Sciences & Entrepreneurship
New Jersey Economic Development Authority (NJEDA)
Kevin Belfield Ph.D.
Dean, College of Science & Liberal Arts
New Jersey Institute of Technology
WHAT CAN CHOOSE New Jersey DO FOR YOU
Relocation & Expansion Services
We provide customized RFI responses, demographics, detailed market assessments and other complimentary business relocation and expansion services. When your company chooses to grow in New Jersey, we also will help you publicize your good news.
Site Visits
We’ll make your property search seamless, so you find the site that best meets your relocation or expansion needs.
Economic Development Connections
Our public and private partners provide a wide range of services. From higher education research collaboration to regulatory and legal assistance to workforce training, they’ll ensure you have a smooth landing.
Carly Wronko
Director of Marketing